| 1 |
Rapaport R, Silverstein JH, Garzarella L, Rosenbloom AL: Type 1 and type 2 diabetes mellitus in childhood in the United States: practice patterns by pediatric endocrinologists. J Pediatr Endocrinol Metab 2004; 17(6): 871-7. |
| 2 |
Beck JK, Logan KJ, Hamm RM, et al.: Reimbursement for pediatric diabetes intensive case management: a model for chronic diseases? Pediatrics 2004; 113(1 Pt 1): e47-50. |
| 3 |
Jack L, Jr., Airhihenbuwa CO, Namageyo-Funa A, Owens MD, Vinicor F: The psychosocial aspects of diabetes care. Using collaborative care to manage older adults with diabetes. Geriatrics 2004; 59(5): 26-31; quiz 32. |
| 4 |
Campbell RK, White J: Counseling patients with type 2 diabetes and insulin resistance in the outpatient setting. Diabetes Educ 2002; 28(6): 938-43, 947-50, 952-4 passim. |
| 5 |
Katon WJ, Von Korff M, Lin EH, et al.: The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61(10): 1042-9. |
| 6 |
Goeddeke-Merickel CM: The goals of comprehensive and integrated disease state management for diabetic kidney patients. Avd Chronic Kidney Dis 2005; 12(2): 236-42. |
| 7 |
Townsend C: Team care for periodontal disease: a model for patient rights. Dent Today 2004; 23(12): 72, 74-5. |
| 8 |
Seaman S: The role of the nurse specialist in the care of patients with diabetic foot ulcers. Foot Ankle Int 2005; 26(1): 19-26. |
| 9 |
Gary TL, Batts-Turner M, Bone LR, et al.: A randomized controlled trial of the effects of nurse case manager and community health worker team interventions in urban African-Americans with type 2 diabetes. Control Clin Trials 2004; 25(1): 53-66. |
| 10 |
Polonsky WH, Earles J, Smith S, et al.: Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program. Diabetes Care 2003; 26(11): 3048-53. |
| 11 |
Wermeille J, Bennie M, Brown I, McKnight J: Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team--a pilot study. Pharm World Sci 2004; 26(1): 18-25. |
| 12 |
Carter BL: Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH. J Manag Care Pharm 2004; 10(5 Suppl A): S18-25. |
| 13 |
Levetan CS, Salas JR, Wilets IF, Zumoff B: Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 1995; 99(1): 22-8. |
| 14 |
Koproski J, Pretto Z, Poretsky L: Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 1997; 20(10): 1553-5. |
| 15 |
Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 1998; 280(17): 1490-6. |
| 16 |
Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329(14): 977-86. |
| 17 |
United Kingdom Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53. |
| 18 |
Gilmer TP, O'Connor PJ, Manning WG, Rush WA: The cost to health plans of poor glycemic control. Diabetes Care 1997; 20(12): 1847-53. |